Literature DB >> 17703957

Spingosine-1-phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes.

M H Stradner1, J Hermann, H Angerer, D Setznagl, I -G Sunk, R Windhager, W B Graninger.   

Abstract

OBJECTIVE: Sphingosine-1-phosphate (S1P) is a messenger molecule, with important functions in inflammation and wound healing. The present study was performed to elucidate a possible role of S1P signaling in articular chondrocytes.
METHODS: Human and bovine primary chondrocytes were cultured in monolayer. Reverse transcriptase polymerase chain reaction (RT-PCR) was performed to detect S1P receptor mRNA. Proliferation of S1P stimulated chondrocytes was measured by 3H-thymidine uptake. Supernatants of cultured bovine chondrocytes stimulated with S1P alone or in combination with interleukin-1beta (IL-1beta) were tested for nitric oxide (NO) formation and expression of inducible nitric oxide synthase (iNOS). Matrixmetalloprotease-13 (MMP-13) and aggrecanase-1 (ADAMTS-4) were evaluated using real-time PCR. Glycosaminoglycan (GAG) loss from bovine cartilage explants was evaluated using the dimethylene blue method.
RESULTS: S1P1, S1P2 and S1P3 but not S1P4 and S1P5 receptor mRNA were detected in human and bovine chondrocytes. S1P dose dependently induced proliferation in bovine and human chondrocytes. S1P significantly reduced NO formation and iNOS mRNA and protein expression, both in un-stimulated and IL-1beta stimulated bovine chondrocytes. Furthermore, S1P dose dependently inhibited IL-1beta induced expression of ADAMTS-4 and MMP-13 and diminished IL-1beta mediated GAG depletion from cartilage explants.
CONCLUSION: These results suggest that S1P provides an anti-catabolic signal in articular chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703957     DOI: 10.1016/j.joca.2007.06.018

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  5 in total

1.  Regulation of MMP3 by laminin alpha 4 in human osteoarthritic cartilage.

Authors:  F C Fuerst; G Gruber; M H Stradner; J C Jones; M L Kremser; H Angerer; D Setznagl; M Glehr; R Windhager; A Leithner; W B Graninger
Journal:  Scand J Rheumatol       Date:  2011-11       Impact factor: 3.641

Review 2.  Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis.

Authors:  Peng-fei Hu; Yi Chen; Peng-fei Cai; Li-feng Jiang; Li-dong Wu
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

Review 3.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

4.  The immunosuppressant FTY720 (fingolimod) enhances glycosaminoglycan depletion in articular cartilage.

Authors:  Martin H Stradner; Hannes Angerer; Thomas Ortner; Florentine C Fuerst; Daniela Setznagl; Marie-Luise Kremser; Josef Hermann; Winfried B Graninger
Journal:  BMC Musculoskelet Disord       Date:  2011-12-12       Impact factor: 2.362

5.  Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes.

Authors:  Martin H Stradner; Gerald Gruber; Hannes Angerer; Verena Huber; Daniela Setznagl; Marie-Luise Kremser; Florentine C Moazedi-Fürst; Reinhard Windhager; Winfried B Graninger
Journal:  Arthritis Rheum       Date:  2013-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.